Microbiology and Virology Research Group

Antimicrobial Resistance Research Group

Principal Investigator: Dr. Saadia Andleeb

Drug Resistant Nosocomial Bugs of Pakistani Communities

Antimicrobial resistance is an urgent public health and economic challenge, and good quality research is a vital part of the response. To help preserve antimicrobials and save lives and livelihoods, our research group aims to focus on surveillance, transmission dynamics across distinct geographies, global boundaries and potential strategies to overcome the bugs.

We address multidrug-resistant challenges in hospital environment including ICU surfaces, emphasizing dominant clones across various microbes with transmission dynamics across distinct geographies. Our work targets persistent multidrug-resistant organisms, explores emerging resistance insights, and develops precision strategies and In-silico vaccines for healthcare-associated challenges. Our Future aim is Typhoid transmission dynamics.

• Globally Parallel Trends in Antibiotic Resistance
• Linezolid Resistance in Enterococcus faecium: A Comparative Genomic Analysis
• Combination Therapy for Drug-Resistant MRSA and P. aeruginosa
• P. aeruginosa & Enterobacteriaceae Colonization Dynamics, Antibiotic Resistance, and Strain-Level Persistence
• Combining Phage and Antibiotics: Precision Strategies Against Biofilm Populations
• Nature inspired antimicrobial peptides against biofilm forming bacteria
• Antimicrobial Sprayble-hydrogels
• Bacteriophages against Multidrug-Resistant Pathogens